Alpine Bank Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$901K Sell
32,090
-1,209
-4% -$32.2K 0.13% 88
2025
Q4
$829K Sell
33,299
-647
-2% -$16.3K 0.12% 87
2025
Q3
$865K Sell
33,946
-514
-1% -$12.7K 0.12% 85
2025
Q2
$835K Hold
34,460
0.13% 83
2025
Q1
$873K Buy
+34,460
New +$902K 0.14% 76
2024
Q3
$928K Buy
+32,064
New +$935K 0.15% 76

Other funds holding PFE

Alpine Bank Wealth Management's PFE Position: Q1 2026 in Review

Alpine Bank Wealth Management reduced its Pfizer (PFE) stake by 3.6% in Q1 2026, selling an estimated $32.2K and leaving 32,090 shares worth $901K. The position accounts for 0.13% of the portfolio, ranked #88.

Alpine Bank Wealth Management first reported a position in PFE in Q3 2024 and has held it in 6 quarters since. The position peaked at $928K in Q3 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Alpine Bank Wealth Management held 32,090 shares of Pfizer worth $901K as of Q1 2026.
  • Alpine Bank Wealth Management sold 1,209 Pfizer shares in Q1 2026, an estimated $32.2K.
  • Pfizer made up 0.13% of Alpine Bank Wealth Management's portfolio in Q1 2026, its #88 holding.
  • Alpine Bank Wealth Management first reported a position in Pfizer in Q3 2024 and has held it in 6 quarters since.
  • Alpine Bank Wealth Management's Pfizer position peaked at $928K in Q3 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.